Clinical Trial Update: Extracellular Signal-Related Kinase Biomarker Development in Autism

View source ↗

Summary

A clinical trial evaluating extracellular signal-regulated kinase (ERK) biomarkers in autism spectrum disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorders

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Autism Spectrum Disorders | Status: COMPLETED